These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9395232

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
    Hasmall S, James N, Hedley K, Olsen K, Roberts R.
    Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
    James NH, Roberts RA.
    Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
    [Abstract] [Full Text] [Related]

  • 7. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).
    Roberts RA, James NH, Woodyatt NJ, Macdonald N, Tugwood JD.
    Carcinogenesis; 1998 Jan; 19(1):43-8. PubMed ID: 9472691
    [Abstract] [Full Text] [Related]

  • 8. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
    James NH, Roberts RA.
    Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
    [Abstract] [Full Text] [Related]

  • 9. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
    Hasmall SC, West DA, Olsen K, Roberts RA.
    Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin.
    Cosulich SC, James NH, Needham MR, Newham PP, Bundell KR, Roberts RA.
    Carcinogenesis; 2000 Sep; 21(9):1757-60. PubMed ID: 10964109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Downregulation of lactoferrin by PPARalpha ligands: role in perturbation of hepatocyte proliferation and apoptosis.
    Hasmall S, Orphanides G, James N, Pennie W, Hedley K, Soames A, Kimber I, Roberts R.
    Toxicol Sci; 2002 Aug; 68(2):304-13. PubMed ID: 12151626
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
    Hasmall SC, James NH, Soames AR, Roberts RA.
    Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators.
    Cosulich S, James N, Roberts R.
    Carcinogenesis; 2000 Apr; 21(4):579-84. PubMed ID: 10753189
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.